Campylobacter Infections Clinical Trial
Official title:
Campylobacter Spp. Bone and Joint Infection: a Retrospective Cohort Study
Campylobacter bacteria, a Gram-negative bacillus commensal in the digestive tract of many animals and mainly responsible for human infections with digestive origins, has been little studied in the field of osteoarticular infections (OAI). Campylobacter spp. are, however, well described, mainly for C. fetus, and pose a dual therapeutic problem: i) a capacity for persistence due to the capacity of most strains to form biofilm; and ii) potential resistance to many antibiotics. The management of IOA caused by Campylobacter spp. is not codified, and is based on small series of cases reported in the literature.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03683667 -
Protein Plus: Improving Infant Growth Through Diet and Enteric Health
|
Phase 2/Phase 3 | |
| Completed |
NCT03266068 -
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
|
||
| Not yet recruiting |
NCT06432777 -
Recurrent Campylobacter Bacteraemia in Immunocompromised Patients
|
||
| Active, not recruiting |
NCT02040922 -
Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota
|
N/A | |
| Recruiting |
NCT01048112 -
Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection
|
Phase 1 | |
| Completed |
NCT04182490 -
LMN-101 in a Campylobacter Human Challenge Model
|
Phase 2 | |
| Active, not recruiting |
NCT00434798 -
Campylobacter Jejuni Challenge Model Development: Dose Ranging Study
|
Phase 1 | |
| Completed |
NCT02884752 -
Retrospective Study of Bone Infection Due to Campylobacter Spp
|
N/A |